GH Research (GHRS) Cash & Equivalents (2021 - 2025)

GH Research's Cash & Equivalents history runs 5 years deep, the most recent figure standing at $246.3 million for Q4 2025.

• On a quarterly basis, Cash & Equivalents rose 144.32% year-over-year to $246.3 million in Q4 2025; TTM through Dec 2025 was $246.3 million, a 144.32% increase from a year earlier, with the FY2025 full-year figure at $246.3 million, up 144.32% from the prior year.
• Cash & Equivalents slipped to $246.3 million in Q4 2025 per GHRS's latest filing, from $249.7 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $280.7 million in Q3 2021 and bottomed at $77.5 million in Q1 2024.
• The 5-year median for Cash & Equivalents is $205.5 million (2022), against an average of $179.6 million.
• Across the five-year window, Cash & Equivalents tumbled 66.36% in 2023 and jumped 216.14% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $276.8 million in 2021, then slumped by 40.04% to $166.0 million in 2022, then slumped by 52.75% to $78.4 million in 2023, then advanced by 28.53% to $100.8 million in 2024, then soared by 144.32% to $246.3 million in 2025.
• Per Business Quant, the three latest GHRS Cash & Equivalents figures stand at $246.3 million (Q4 2025), $249.7 million (Q3 2025), and $253.9 million (Q2 2025).